![Edward Kolb](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edward Kolb
Directeur Général chez The Leukemia & Lymphoma Society, Inc.
Postes actifs de Edward Kolb
Sociétés | Poste | Début | Fin |
---|---|---|---|
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Directeur Général | 01/05/2023 | - |
President | 01/05/2023 | - |
Historique de carrière de Edward Kolb
Formation de Edward Kolb
Thomas Jefferson University | Doctorate Degree |
University of Pennsylvania | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Chief Executive Officer | 1 |
President | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
- Bourse
- Insiders
- Edward Kolb
- Expérience